NCT06943404: BXCL501 After Stress to Increase Recovery Success
- State
- Under way
- Phase
- Phase 2
- People
- 100 planned
- Started
- 23 Feb 2026
- Primary completion
- 29 Sep 2026
- Arms
- BXCL501 (dexmedetomidine HCl)
- Results
- None posted
- 24 Apr 2025: Trial registered
- 23 Feb 2026: Trial started